Russian doctors receive comprehensive training in MDR-TB

MDR-TB Training
Novosibirsk MDR-TB Training

TB patient in Russia
TB patient in Russia

 

Doctors from all 26 territories in Siberia and the Far East of Russia received comprehensive training in detection, prevention and treatment of multidrug-resistant TB through a 10-day program held in Novosibirsk in late March. The training program was developed by Partners In Health faculty in collaboration with the Russian Ministries of Health and Justice and the World Health Organization (WHO) and was sponsored by the Novosibirsk Tuberculosis Research Institute.

Since the collapse of the Soviet Union, Russia's public health services have deteriorated rapidly and TB, which had previously been well controlled, has reemerged with a vengeance. Prevalence rates of MDR-TB are now among the highest in the world. In some areas of Russia, 14 percent of new cases and 26 percent of previously treated cases are multidrug-resistant. In the prison  system, nearly one quarter of all new TB cases are drug-resistant.

Over the course of the program, 74 doctors from both the civilian and prison health systems took part in an interactive, comprehensive review of the many aspects of medical treatment and prevention of MDR-TB, along with practical recommendations for MDR-TB management in the Russian Federation.

Faculty for the training included six doctors affiliated with PIH in Boston, Tomsk and at the Division of Social Medicine and Health Inequalities at Brigham and Women’s Hospital. They were joined by other faculty from the Russian Ministry of Health, the Novosibirsk TB Research Institute, Moscow Medical Academy, WHO and the Tomsk Oblast MDR-TB Project.

The Eli Lilly Foundation provided most of the funding for the training. Additional financial support came from the WHO and the Russian Healthcare Foundation.

The next round of training for another 25 territories will be held near Moscow in late June, sponsored by the Moscow Medical Academy.

[posted April 2006]

comments powered by Disqus